If you have any questions about the videos or this page, please contact our Marketing Specialist, Silvie Pradhan.

Curia's Origgio Site: Scaling Up for Global Health through Rapid LNP Industrialization

One of Curia's contributions to combating the COVID-19 pandemic was the rapid industrialization of Lipid Nano Particles (LNPs) production at our Origgio facility. These particles are a crucial delivery platform for mRNA, which was essential in the production of COVID-19 vaccines to people all around the world. Discover more in the video.

Embed